AtriCure (ATRC) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
AtriCure insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $4.4M of ATRC stock on the open market.
Get emailed when insiders cluster-buy stocks like ATRC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ATRC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $3.3M | 10 |
| Q2 2026 | — | 0 | $227K | 2 |
| Q1 2026 | — | 0 | $149K | 1 |
| Q4 2025 | — | 0 | $676K | 4 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 AtriCure, Inc. insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $4.4M. 3 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 24SEC | Salvatore PriviteraChief Technical Officer | Sell Plan | 4,519142,745 held (−3%) | $60.00 | $271K | -7.0% | — |
| Sep 14SEC | Regina E GrovesDirector | Sell | 5,31334,546 held (−13%) | $54.22 | $288K | +2.9% | — |
| Sep 10SEC | Salvatore PriviteraChief Technical Officer | Sell Plan | 3,657147,264 held (−2%) | $55.00 | $201K | +1.5% | — |
| Sep 4SEC | Salvatore PriviteraChief Technical Officer | Sell Plan | 7,763150,921 held (−5%) | $52.50 | $408K | +6.3% | — |
| Aug 26SEC | Karl S. DahlquistGeneral Counsel | Sell | 9,37087,319 held (−10%) | $48.89 | $458K | +14.2% | — |
| Aug 7SEC | Karen PrangeDirector | Sell | 3,56422,809 held (−14%) | $38.80 | $138K | +43.8% | — |
| Aug 7SEC | Maggie YuenDirector | Sell | 3,50014,015 held (−20%) | $38.42 | $134K | +45.3% | — |
| Jul 30SEC | Sven WehrweinDirector | Sell | 25,00040,518 held (−38%) | $37.84 | $946K | +47.5% | — |
| Jul 30SEC | Justin J NozneskyChief Mktg & Strategy Officer | Sell | 6,182100,219 held (−6%) | $38.80 | $240K | +43.8% | — |
| Jul 30SEC | Vinayak DoraiswamyChief Scientific Officer | Sell | 6,00086,511 held (−6%) | $38.88 | $233K | +43.5% | — |
| May 22SEC | Karen PrangeDirector | Sell | 3,00026,373 held (−10%) | $28.65 | $86K | +94.8% | — |
| May 18SEC | Vinayak DoraiswamyChief Scientific Officer | Sell | 5,00091,875 held (−5%) | $28.13 | $141K | +98.4% | — |
| Mar 16SEC | Vinayak DoraiswamyChief Scientific Officer | Sell | 5,00096,875 held (−5%) | $29.83 | $149K | +87.1% | — |
| Nov 26SEC | Justin J NozneskyChief Mktg & Strategy Officer | Sell | 5,16678,798 held (−6%) | $37.29 | $193K | +49.7% | — |
| Nov 26SEC | Sven WehrweinDirector | Sell | 4,96734,374 held (−13%) | $38.00 | $189K | +46.9% | — |
| Nov 26SEC | Sven WehrweinDirector | Sell | 5,03334,374 held (−13%) | $37.32 | $188K | +49.5% | — |
| Nov 25SEC | Maggie YuenDirector | Sell | 3,00011,371 held (−21%) | $35.72 | $107K | +56.2% | — |
Insiders at AtriCure, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Sven WehrweinDirector | — | $1.3M | Jul 30, 2026 | — |
| Salvatore PriviteraChief Technical Officer | — | $880K | Sep 24, 2026 | — |
| Vinayak DoraiswamyChief Scientific Officer | — | $523K | Jul 30, 2026 | — |
| Karl S. DahlquistGeneral Counsel | — | $458K | Aug 26, 2026 | — |
| Justin J NozneskyChief Mktg & Strategy Officer | — | $433K | Jul 30, 2026 | — |
| Regina E GrovesDirector | — | $288K | Sep 14, 2026 | — |
| Maggie YuenDirector | — | $242K | Aug 7, 2026 | — |
| Karen PrangeDirector | — | $224K | Aug 7, 2026 | — |
ATRC stock: common questions
Are AtriCure, Inc. insiders buying ATRC stock?
In the past 12 months, 0 insiders reported open-market purchases of ATRC worth $0.
Are AtriCure, Inc. insiders selling ATRC stock?
8 insiders reported sales worth $4.4M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ATRC's 52-week range?
Over the past year ATRC has traded between $25.86 and $60.77. It last closed at $55.81 on Oct 9, 2026.